RIMASYS

Exit

RIMASYS offers prefractures specimen for educational purposes in the field of orthopedic surgery. The innovative MedTech company is setting new standards in surgical education and implant development through innovative education and validation with life-like fractured human specimen.

Press releases

Press
10. October 2017
The game changer in surgical education – breaking bones for better patient outcomes
Cologne based MedTech start-up RIMASYS received financing from investor HTGF. The investment will be utilized to expand the fracture portfolio, upgrade production technology and increase international reach. RIMASYS is the worldwide sole manufacturer of life-like fractures in human specimen with intact soft tissue mantle. Enabling medical science to enhance surgical skills and the health care industry to develop better implants will result in improved patient outcomes at a lower cost of care. No
 

Info & Contact

Phone:
+49 (0) 221 500 576 71
Web:
www.rimasys.com/de

Address

Rimasys GmbH
Nattermannallee 1
50829 Köln

In portfolio

04. Oct 2017 – 03. Apr 2021

HTGF Manager

 
Dr. Anke Caßing, Principal / Authorized Signatory
Exit